ReviewCurrent oncology (Toronto, Ont.)2023

Clinical Efficacy and Openness to New Challenges of Low Dose Rate Brachytherapy for Prostate Cancer.

Manabu Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.